Theoretical Study of Molecular Structure and Physicochemical Properties of Novel Factor Xa Inhibitors and Dual Factor Xa and Factor IIa Inhibitors-Reference-Cited by-同舟云学术

Theoretical Study of Molecular Structure and Physicochemical Properties of Novel Factor Xa Inhibitors and Dual Factor Xa and Factor IIa Inhibitors

Published:2016-02-04 Issue:2 Volume:21 Page:185
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Remko Milan,Remková Anna,Broer Ria^ORCID

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/21/2/185/pdf

Reference56 articles.

1. A comprehensive review of vitamin K and vitamin K antagonists;Vermeer;Hematol. Oncol. Clin. N. Am.,2000

2. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: A review of the literature

3. New Oral Anticoagulants: Comparative Pharmacology with Vitamin K Antagonists

4. Factor Xa inhibitors: Next-generation antithrombotic agents;Pinto;J. Med. Chem.,2010

5. Direct oral anticoagulants: New drugs and new concepts;Levy;JACC Cardiovasc. Interv.,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrochemical oxidation of edoxaban and its determination in pharmaceutical samples and human serum;Microchemical Journal;2024-09

2. Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa;Molecules;2024-01-11

3. First-in-human trial of SAR107375E, a novel small molecule anticoagulant with dual inhibition of factor Xa and factor IIa;Expert Opinion on Investigational Drugs;2023-11-02

4. Synthesis and characterization of novel imino derivatives of acenocoumarol: chiral separation, absolute configuration and determination of biological activity;New Journal of Chemistry;2023

5. Biopharmaceutics considerations for direct oral anticoagulants;Drug Development and Industrial Pharmacy;2021-12-02